Cabaletta Bio Stock Piotroski F Score
CABA Stock | USD 13.34 0.63 4.51% |
Cabaletta | Piotroski F Score |
At this time, it appears that Cabaletta Bio's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
Current Return On Assets | Negative | Focus |
Change in Return on Assets | Decreased | Focus |
Cash Flow Return on Assets | Negative | Focus |
Current Quality of Earnings (accrual) | Improving | Focus |
Asset Turnover Growth | No Change | Focus |
Current Ratio Change | Increase | Focus |
Long Term Debt Over Assets Change | N/A | Focus |
Change In Outstending Shares | Decrease | Focus |
Change in Gross Margin | No Change | Focus |
Cabaletta Bio Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Cabaletta Bio is to make sure Cabaletta is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Cabaletta Bio's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Cabaletta Bio's financial numbers are properly reported.
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Total Current Liabilities | 16.8 M | 16 M |
|
| |||||
Non Current Liabilities Total | 1.4 M | 1.5 M |
|
| |||||
Total Assets | 266.3 M | 253.7 M |
|
| |||||
Total Current Assets | 256.7 M | 244.5 M |
|
|
Cabaletta Bio F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Cabaletta Bio's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Cabaletta Bio in a much-optimized way.
-0.57 | 0.23 | -0.1 | 0.49 | 0.5 | -0.17 | ||
-0.57 | -0.9 | 0.03 | -0.98 | -0.99 | 0.89 | ||
0.23 | -0.9 | -0.09 | 0.96 | 0.95 | -0.98 | ||
-0.1 | 0.03 | -0.09 | -0.05 | -0.05 | 0.13 | ||
0.49 | -0.98 | 0.96 | -0.05 | 1.0 | -0.93 | ||
0.5 | -0.99 | 0.95 | -0.05 | 1.0 | -0.92 | ||
-0.17 | 0.89 | -0.98 | 0.13 | -0.93 | -0.92 |
Click cells to compare fundamentals
About Cabaletta Bio Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
About Cabaletta Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cabaletta Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cabaletta Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cabaletta Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock: Check out Cabaletta Bio Altman Z Score, Cabaletta Bio Correlation, Cabaletta Bio Valuation, as well as analyze Cabaletta Bio Alpha and Beta and Cabaletta Bio Hype Analysis. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.65) | Return On Assets (0.25) | Return On Equity (0.40) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.